3rd Quarter - Report

PMI US CORPORATE SERVICES INC. (FKA PMI GLOBAL SERVICES INC.) for PMI US CORPORATE SERVICES INC. (FKA PMI GLOBAL SERVICES INC.)

Firm
Client
Income
—
Expenses
$1,690,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Discussions related to federal excise tax drawback laws and their application to manufacturing of tobacco products

LobbyistCovered position, as disclosed
KELLY LUNGREN MCCOLLUM —
MOYER MCCOY —
ZACH PAULSEN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Tobacco TOB

H.R. 9425: Tobacco User Fee Modernization Act of 2024; all provisions Discussions related to implementation of P.L. 111-31 - Family Smoking Prevention and Tobacco Control Act Discussions related to tobacco harm reduction and reduced risk products Discussions related to enforcement of illicit tobacco products, including importation of counterfeit products Discussions related to user fees for tobacco and electronic nicotine delivery system products Discussions related to efforts to prevent youth access to tobacco products

LobbyistCovered position, as disclosed
KEAGAN R LENIHAN —
KELLY LUNGREN MCCOLLUM —
MOYER MCCOY —
ZACH PAULSEN —
DIEGO ZAMBRANO —

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE

Bills named: H.R. 9425 (118th)

Foreign Relations FOR

Discussions related to international regulation of tobacco products Discussions related to U.S. policy guidance provided to executive branch personnel

LobbyistCovered position, as disclosed
ZACH PAULSEN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Government Issues GOV

Discussions related to federal funding for the Centers for Disease Control and Prevention

LobbyistCovered position, as disclosed
ZACH PAULSEN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Discussions related to tobacco harm reduction and alternative nicotine products for adults

LobbyistCovered position, as disclosed
KEAGAN R LENIHAN —
KELLY LUNGREN MCCOLLUM —
MOYER MCCOY —
ZACH PAULSEN —
DIEGO ZAMBRANO —

Contacted: SENATE; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.